Video Experimental Relacionado
Updated: May 2, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Proptosis bilateral como primera manifestación en un paciente con leucemia mieloide aguda: reporte de caso
Ruba Edrees1, Mary Hazeem2, Maged Kheder3
1Department of Pediatrics, Children's University Hospital, Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.
Rationale:
Myeloid sarcoma (MS), also known as granulocytic sarcoma or chloroma, is a rare manifestation of acute myeloid leukemia (AML) that occurs concurrently with, following, or rarely before the onset of leukemia. It consists of immature myeloid cells that proliferate in extramedullary tissues. Owing to the rare association between bilateral proptosis and AML, it is often misdiagnosed as other conditions that present with proptosis, such as infections (as in our case), vascular lesions, or tumors, particularly rhabdomyosarcoma and neuroblastoma, creating a diagnostic dilemma.
Patient Concerns:
We report a case of MS that initially presented with bilateral proptosis and was misdiagnosed as orbital cellulitis. A child of Syrian origin presented with rapidly progressive bilateral proptosis that had started 2 weeks prior to admission. Her medical history was unremarkable except for a blood transfusion 2 months earlier. She initially received treatment for suspected conjunctivitis and then for orbital cellulitis with intravenous antibiotics, with no clinical improvement. On examination, she appeared pale and fatigued. Ophthalmic examination revealed severe bilateral eyelid edema with proptosis and conjunctival chemosis.
Diagnoses And Interventions:
MS was diagnosed based on laboratory tests, bone marrow examination, and computed tomography imaging. A complete response was achieved dramatically after 1 month of treatment with the standard chemotherapy regimen.
Outcomes:
This case highlights the various aspects of AML in children and aims to draw clinicians' attention to the possible diagnosis of AML in a patient with proptosis, which may lead to earlier diagnosis and treatment.
Lessons:
This case raises awareness among clinicians to consider AML in the differential diagnosis of any child with unilateral or bilateral proptosis, even in the absence of systemic symptoms of leukemia.

